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Introduction
The 2000 United States (US) Census counted 206,000
Cambodians. Over 99% of Cambodian Americans came
to the US as refugees or immigrants over the last three
decades, or are the children of these individuals
(Niedzwiecki and Tuong, 2004). Further, approximately
90% of Cambodian adults aged 20 years and older are
foreign-born (Taylor et al., 2009). Cambodian Americans
are economically and educationally disadvantaged (29%
live below the Federal poverty level and 53% have less
than a high school education), and linguistically isolated
(92% speak Khmer at home and only 46% speak English
very well or fluently) (Department of Commerce, 2004).
However, this underserved population has received very
little attention from health disparity researchers (Ghosh,
2003). The majority of Cambodian Americans live in one
of three states: California, Massachusetts, or Washington
(Niedzwiecki et al., 2004).
Cambodian American women experience a cervical
cancer disparity. Specifically, the cervical cancer incidence
rate among Cambodian Americans in California and the
Puget Sound area of Washington State is 15.0 per 100,000
women, compared to 7.7 per 100,000 among non-Hispanic
white women (Kem and Chu, 2007). HPV infection has
been identified as a universal risk factor for cervical cancer
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(Parkin, 2006). Consequently, the US Food and Drug
Administration (FDA) approved the quadrivalent HPV
vaccine (HPV 16, HPV 18, HPV 6, and HPV 11) for
children, adolescents, and young women aged nine to 26
years in 2006 (Markowitz et al., 2007). A recent
population-based survey assessed HPV vaccine
acceptability among Californian parents of daughters who
were age-eligible for the HPV vaccine, and found that
Asian Americans were significantly less likely to accept
the HPV vaccine than non-Hispanic whites and Hispanics
(Constantine and Jerman, 2007).
Qualitative methods are useful tools for investigating
a new area of research and developing new intervention
programs (Farquhar et al., 2006). They are also appropriate
when conducting research in communities about which
little information exists (Matthews et al., 2000). Very few
studies have examined HPV vaccination awareness in
Southeast Asian populations. We conducted a qualitative
study addressing HPV vaccine knowledge and beliefs
among Cambodians living in Seattle, Washington during
2008 (shortly after FDA approval of the HPV vaccine)
(Markowitz et al., 2007). Our brief report provides
qualitative information that could be used to guide future
quantitative data collection efforts in Cambodian
American communities, as well as the development of
HPV educational materials and intervention programs.
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Materials and Methods
Key Informant Interviews
We conducted 13 key informant interviews with local
Cambodian leaders (who need to know about the HPV
vaccine so that they can promote vaccination coverage in
their community). Our research group has collaborated
with a Cambodian Community Coalition on multiple
health-related projects for over a decade. The community
leaders included individuals who serve on the Cambodian
Community Coalition, as well as other Cambodians who
work with organizations that serve Cambodians (identified
by Coalition members). Interviews were conducted by a
Cambodian staff member (either at the community leader’s
workplace or a local community center), and lasted about
30 minutes. Because all the Cambodian leaders spoke
English fluently, the interviews were conducted in English
(to avoid unnecessary translation costs). Each community
leader received a small honorarium for completing an
interview as a token of appreciation for his/her time.
Focus Groups
We held four focus groups. Two of the groups included
fathers and two included mothers. Eligibility criteria
included being of Cambodian descent, being able to speak
and understand Khmer, and having at least one daughter
who was age-eligible for the HPV vaccine (i.e., in the 9-
26 age-group). We chose four focus groups because the
topic is reasonably complex, and approximately 10
participants per group because this size is large enough to
get a variety of viewpoints and yet small enough for
participants to have opportunities to express themselves
(Morgan, 1988). It should be noted that Morse has
suggested that 30 to 40 focus group participants provide
sufficient breadth of input to explore a new area (Morse,
2000). We segmented the groups by gender to ensure that
all participants felt comfortable giving their opinions.
The focus group participants were recruited from two
community-based organizations that serve the Cambodian
community in metropolitan Seattle: the Cambodian
Women’s Association and Khmer Community of Seattle–
King County. Focus groups were held at the community-
based organization offices (because of their proximity to
Cambodian neighborhoods and easy access via public
transportation), and lasted approximately two hours. A
bilingual (Khmer and English speaking) Cambodian
facilitator conducted the focus groups in Khmer. Focus
group participants were offered a small honorarium, as
well as refreshments during the focus group sessions.
Questions
Key informant interview and focus group participants
were asked whether they had heard of HPV and the HPV
vaccine. They were then read the following statement:
“A HPV vaccine has recently been approved for use in
the US. The government has approved HPV vaccinations
for all females aged nine to 26 years. The HPV vaccine
can prevent most cervical cancers in women.” After the
statement had been read to them, participants were asked
a series of questions about the HPV vaccine. For example,
participants were asked the following questions: Why did
you have your daughter(s) vaccinated? Why have you
not had your daughter(s) vaccinated? Why do you think
some Cambodian parents will get their daughter(s)
vaccinated? Why do you think some Cambodian parents
will not get their daughter(s) vaccinated? What concerns
do you have about HPV vaccinations? What information
about HPV vaccinations would you find useful?
Data Analysis
We transcribed the focus group sessions verbatim in
Khmer and transcribed the key informant interviews
verbatim in English. Additionally, the focus group
transcripts were translated into English (for review by
staff members who did not speak Khmer). Three members
of the research team independently coded the transcripts
for thematic content. These coders met regularly to review
and summarize the key themes that emerged from the
key informant interviews and focus group sessions (Pope
and Mays, 1995).
Results
Study Group Characteristics
Six of the 13 key informants were men and 10 were
40 years of age or older. All the community leaders had
at least 14 years of education, 12 were currently married,
11 were born in Cambodia, and 12 had been in the US
for at least 10 years. Seven of the community leaders
had daughters who were age-eligible for the HPV vaccine.
The characteristics of our focus group participants are
given in Table 1. Nearly all (97%) were born in
Cambodia, 41% had lived in the US for less than 10 years,
and 54% had limited English proficiency.
General Findings
Ten of the community leaders had heard of HPV and
eight had heard of the HPV vaccine (before they were
read the HPV vaccine statement). Three of the seven
Table 1. Characteristics of the Focus Group
Participants
Characteristic Category N %
Gender Male 18 49
Female 19 51
Age in years <40 11 30
≥40 26 70
Education in years <12 22 59
 ≥12 15 41
Currently married Yes 28 76
No   9 24
Country of birth Cambodia 36 97
Other   1   3
Years in US <10 15 41
≥10 22 59
Spoke English very well or fluently
Yes 17 46
No 20 54
Number of age-eligible daughters
1 24 65
≥2 13 35
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community leaders with daughters who were age-eligible
for the HPV vaccine said their daughters had already been
vaccinated. Very few of the focus group participants had
heard of HPV or the HPV vaccine. There was some
confusion between HPV and HIV/AIDS. Only a couple
of focus group participants said their daughters had
received the HPV vaccine. Many male focus group
participants did not know whether their daughters had
received the HPV vaccine or not, and indicated that this
was the type of topic that they did not discuss with their
daughters.
Barriers and Facilitators
Table 2 provides examples of key informant and focus
Because of the benefit. It’s a benefit for their health. It’s
something that can prevent them from getting cervical
cancer in the future. [Man aged 30-39] Whether a vaccine
is for cervical cancer or other, most do not understand
the importance of prevention until they get the disease.
[Man aged 60-69]
Some parents believe in traditional medicine more than
Western medicine. That’s why they don’t allow their
daughters to get the vaccine. [Man aged 50-59]I don’t
think a lot of people get their kids vaccinated because of
the culture…whatever is going to happen will happen.
[Woman aged 40-49]
It’s not known that it is there and available. [Woman
aged 20-29] All of my kids had hepatitis A, B, and C
shots. But this is something new and we don’t know.
[Woman aged 30-39] I believe that there’s not enough
education, information, or outreach. If people are not
clear, they may not be willing to do it until they have the
information. [Woman aged 40-49]
Probably they feel like their daughters are not at the age
to be sexually active. [Man aged 40-49] My friends said
don’t let her get the vaccine because she has not done
anything. [Woman aged 40-49] Because I don’t think
my children have sexual activities. [Woman aged 40-
49]
If they knew more about it and what it is for, they
probably would say no because they would think it would
promote promiscuity. [Woman aged 20-29] Because they
want their kids to not sleep around. [Woman aged 40-
49]
I don’t know the side effects or consequences of getting
it. [Man aged 30-39] Well, I have to do more research
on that. If it’s very safe for them, I’ll do it. Right now, it
was just approved. [Man aged 40-49] They told me it
causes health problems later on. [Woman aged 40-49] I
am concerned it’s going to affect other parts of their body.
[Woman aged 40-49]
The effectiveness is important. I need information that
it is very effective. [Man aged 40-49] I want to know
how effective it is. [Man aged 40-49]
Cambodians can’t afford the vaccine if it costs too much.
[Man aged 60-69] Well, if it costs money and people
don’t have health insurance or don’t have a lot of money,
they probably won’t get it. [Woman aged 20-29]
I have not been told by my doctor to have my daughter
vaccinated [Man aged 60-69]. Because I trust the medical
experts and I have hung around with other health care
providers and they say that it is good to have it [Woman
aged 40-49].Well, we didn’t know. Our doctor didn’t
remind us or tell us about HPV [Woman aged 40-49].
Table 2. Barriers and Facilitators
Factor      Examples of Key Informant Quotes            Examples of Focus Group Participant Quotes
Prevention is better than treatment. It costs less and
saves time. [Man] Prevention is better than waiting
until you get it. [Woman] I think if you are going to
have the disease, you will get it whether you have the
vaccine or not. [Woman]
I personally never thought it is necessary until you
are actually infected with it. [Man] I have not heard
of it and that’s why they are not vaccinated. [Man] I
have daughters but I didn’t know there is a vaccine.
[Woman] If they knew the vaccine is available, they
would have their daughters vaccinated. Nobody wants
their daughters to be sick. [Woman]
It is new. What if you got the shot and die. [Man]
Some women become infertile forever. [Man] I am
concerned that the vaccine may cause other health
problems. [Woman] I am afraid that it may cause other
major health problems equal to cervical cancer.
[Woman]
I am concerned that it is not effective with some
people. [Man] My concern is how effective it is and
what is the proven success rate of the vaccine. [Man]
I am concerned about those who work, have children,
and do not have health insurance. Their income is
little, and having to get their daughters vaccinated
may cause financial hardship. [Man] My concern is
the cost. Some families have many daughters. [Man]
Even though they know that the vaccine is available,
some parents do not get their daughters vaccinated
because the cost can be too much. [Woman]
Most doctors have not told us about the HPV vaccine.
[Man] Some parents do not understand. The doctor
needs to explain to them carefully. [Woman] My
doctor recommended it. For prevention. [Woman]
If they said I have to have my daughter vaccinated I
would. I believe my doctor. [Woman]
Beliefs about
prevention
Traditional
beliefs
Lack of
knowledge
Beliefs about
sexual
activity
Beliefs about
promiscuity
Concerns
about safety
Concerns
  about
 effectiveness
Concerns about
cost
Communication
with healthcare
providers.
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group participant quotes about HPV vaccine barriers and
facilitators. Both the key informants and focus group
participants indicated the following factors could influence
HPV vaccine uptake in the Cambodian community: beliefs
about prevention; lack of knowledge; concerns about HPV
vaccine safety, effectiveness, and costs; and healthcare
provider communication issues. They indicated that beliefs
about disease prevention could both positively and
negatively impact HPV vaccine use. Similarly, a
healthcare provider recommendation for vaccination was
described as a facilitator and the absence of a healthcare
provider recommendation was described as a barrier. The
key informants and focus group participants almost
uniformly identified lack of knowledge about the
availability of the HPV vaccine and basic information
about the HPV vaccine as important barriers to its use.
Some of our key informants thought that traditional
Cambodian beliefs might negatively affect HPV vaccine
use; the vaccine is unnecessary for young Cambodians
because they are not sexually active; and parents might
not permit their daughters to be vaccinated because HPV
vaccine receipt could promote promiscuity.
Information
The key informants and focus group participants
thought that the following would be useful to the
Cambodian community: information about who is eligible
for the HPV vaccine, how often the vaccine should be
given, and how long the vaccine lasts. Additionally, they
thought information about the benefits and side effects of
vaccination would be important. Finally, the key
informants and focus group participants wanted
information about healthcare providers and clinics that
offer the HPV vaccine, as well as vaccine costs and
medical insurance coverage of the vaccine.
Discussion
The Centers for Disease Control and Prevention, in
partnership with the American Academy of Pediatrics,
launched a campaign in 2007 that promoted use of
recommended vaccines for 11 and 12 year olds (including
HPV for girls); and the HPV vaccine was actively
marketed in the US through direct consumer advertising
and public awareness campaigns by the manufacturer
(Shefer et al., 2008).  A recent survey of Pennsylvania
and Virginia residents indicated that a majority of the
general US population has heard of HPV infection and
HPV vaccination. Specifically, 95% of Pittsburgh
(Pennsylvania) and 90% of Hampton (Virginia) adults had
heard of HPV, and 92% of Pittsburgh adults and 74% of
Hampton adults had heard of the HPV vaccine (Ragin et
al., 2009). In contrast, we found that very few of our
Cambodian focus group participants were aware.
Brewer and Fazekas recently reviewed studies of HPV-
related beliefs and HPV vaccine acceptability. Their
systematic review indicated that most parents were
positive about vaccinating their daughters against HPV.
Vaccination acceptability was higher when people
believed the vaccine was effective, a physician would
recommend it, and HPV infection was likely. Cost and
concerns that vaccination would promote adolescent
sexual behavior were barriers to vaccination (Brewer and
Fazekas, 2007).
The HPV vaccine is relatively expensive (over $300
for the three-dose series) and we found that financial costs
are an important barrier to HPV vaccine uptake by
Cambodian parents (who may have multiple daughters
who are age-eligible for vaccination). However, the
Vaccines for Children program covers the cost of
vaccination for Medicaid-eligible and uninsured children
and adolescents up to the age of 18 years (Shefer et al.,
2008). Efforts to promote the HPV vaccine in Cambodian
and other economically disadvantaged communities
should provide information about facilities that offer HPV
vaccination though the Vaccines for Children program.
Dinh and colleagues conducted a HPV vaccine
acceptability survey in Da Nang, Vietnam. An
overwhelming majority (95%) of mothers with age-
eligible daughters indicated that a recommendation from
their doctor would be very important in their vaccine
decision-making, and 78% indicated the media would be
very important (Dinh et al., 2007). Physician
recommendation has also been shown to be strongly
associated with cervical cancer screening participation
among Cambodian American and Vietnamese American
women (Nguyen et al., 2002; Taylor et al., 1999; Taylor
et al., 2004). As in other US populations, healthcare
provider endorsement will likely be a key determinant of
HPV vaccine acceptance by Cambodian parents and
potential vaccine recipients (Brewer et al., 2007).
Healthcare providers who serve Cambodian communities
should be encouraged to recommend HPV vaccination,
and Cambodian parents should be empowered to ask
healthcare providers for vaccination.
In conclusion, our findings indicate that information
about the HPV vaccine has not been disseminated to the
US Cambodian community. They also indicate that
Cambodian community leaders and parents would like
more information about the HPV vaccination so that they
can make informed decisions about vaccination. Culturally
and linguistically appropriate HPV vaccine audio-visual
and print educational materials should be developed for
Cambodian Americans. Educational programs should
emphasize that the vaccine is safe and effective in
preventing cervical cancer, as well as the importance of
giving the vaccine before the onset of sexual activity
(Sherris et al., 2006). HPV vaccine outreach efforts should
target Cambodian Americans through the community-
based organizations and healthcare facilities that serve
them, as well as Khmer language media outlets.
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